Full Schedule

Speaker: Nikhil Munshi, MD – Dana-Farber Cancer Institute, Harvard Medical School

Speaker: Peter Campbell – The Wellcome Trust Sanger Inst

Chair: Nikhil Munshi, MD – Dana-Farber Cancer Institute, Harvard Medical School

Co-Chair: Faith E. Davies, MD (she/her/hers) – Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA

Speaker: Faith E. Davies, MD (she/her/hers) – Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA

Speaker: Karin Vanderkerken, PhD (she/her/hers) – Vrije Universiteit Brusssels

Speaker: Madhav V. Dhodapkar, MD, MBBS (he/him/his) – Winship Cancer Institute, Emory University, Atlanta, GA, USA

Speaker: Sigurdur Y. Kristinsson, MD, PhD – University of Iceland

Speaker: Anthony Cirrincione, PhD – Myeloma Service, Sylvester Comprehensive Cancer Center, University of Miami

Speaker: Wen Zhou, PhD – Cancer Research Institute, Xiangya School of Medicine, Central South University

Speaker: Rodger E. Tiedemann, MD, PhD (he/him/his) – Princess Margaret Cancer Centre

Speaker: Leif Bergsagel, MD – Mayo Clinic Arizona

Panelist: Rafael Fonseca, MD – Division of Hematology/Oncology, Mayo Clinic, Phoenix, AZ, USA

Panelist: Andrew Spencer, MBBS FRACP, FRCPA, DM – Alfred Health-Monash University

Panelist: Rodger E. Tiedemann, MD, PhD (he/him/his) – Princess Margaret Cancer Centre

Panelist: Marta Chesi, PhD (she/her/hers) – Mayo Clinic Arizona

Co-Chair: Monica Morris, MSc, RN – Myeloma UK

Co-Chair: Ioanna Tsatsou

Co-Chair: Monica Morris, MSc, RN – Myeloma UK

Co-Chair: Ioanna Tsatsou

Speaker: Evangelos Terpos, MD, PhD (he/him/his) – Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Greece

Speaker: Gordon Cook, PhD – Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK

Speaker: Jessica Chen, MS, FNP – MD Anderson Cancer Center

Speaker: Donna D. Catamero, ANP-BC – Mount Sinai Hospital

Speaker: Chloe Ray, AGPCNP-BC, OCN – Mount Sinai Hospital

Co-Chair: Beth Faiman, PhD, MSN, APN-BC,BMTCN, AOCN, FAAN, FAPO – Cleveland Clinic Taussig Cancer Institute, Department of Hematology and Medical Oncology

Co-Chair: Matthias Hellberg-Naegele, MSc – Comprehensive Cancer Center Zurich

Speaker: Orla McCourt, PhD MCSP – University College London NHS Foundation Trust

Speaker: Joanne S. Land, BSc (she/her/hers) – NHS University College London Hospital, London, United Kingdom

Speaker: Emma Dowling, RN BSC – HCA Healthcare UK

Speaker: Houry Leblebjian

Speaker: Charise Gleason, NP-C – Winship Cancer Institute of Emory University

Speaker: Hermann Einsele, MD, FRCP (he/him/his) – Universitätsklinikum Würzburg, Medizinische Klinik und Poliklinik II, Würzburg, Germany

Speaker: Hermann Einsele, MD, FRCP (he/him/his) – Universitätsklinikum Würzburg, Medizinische Klinik und Poliklinik II, Würzburg, Germany

Speaker: Yi Lin, MD, PHD – Mayo Clinic, Rochester, MN, USA

Speaker: Bruno Paiva, PhD – Clínica Universidad de Navarra (CUN), Centro de Investigación Médica Aplicada (CIMA LAB Diagnostics), IDISNA, CIBERONC

Speaker: Rakesh Popat, MD, PhD – University College London Hospitals NHS Foundation Trust

Chair: Rakesh Popat, MD, PhD – University College London Hospitals NHS Foundation Trust

Co-Chair: Tiffany Richards

Co-Chair: Andrea D. Preston, MRPharmS (Consultant) (she/her/hers) – NHS / Sanius Health

Speaker: Tracy King, PhD, MN, RN – Royal Prince Alfred Hospital, The University of Sydney

Speaker: Monica Morris, MSc, RN – Myeloma UK

Speaker: Urvi A. Shah, MD (she/her/hers) – Myeloma Service, Memorial Sloan Kettering Cancer Center

Speaker: Rebecca Lu, MSN, FNP-C – MD Anderson

Speaker: Tracy King, PhD, MN, RN – Royal Prince Alfred Hospital, The University of Sydney

Chair: Maria-Victoria Mateos, PhD (she/her/hers) – University Hospital of Salamanca

Co-Chair: S. Vincent Rajkumar, MD – Mayo Clinic

Speaker: Saad Z. Usmani, MD MBA FACP – Memorial Sloan Kettering Cancer Center

Speaker: Aurore Perrot, MD, PhD – CHU de Toulouse, IUCT-O, Université de Toulouse, UPS, Service d’Hématologie, Toulouse, France

Speaker: Kwee L. Yong, PhD (she/her/hers) – University College London Cancer Institute, London, UK

Speaker: Evangelos Terpos, MD, PhD (he/him/his) – Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Greece

Speaker: Thomas Lund, MD, PhD (he/him/his) – Department of Hematology Odense University Hospital

Speaker: Lisa B. Leypoldt, MD (she/her/hers) – University Medical Center Hamburg-Eppendorf, Germany / Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. Department of Medicine, Harvard Medical School, Boston, MA, USA. Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA. Department of Hematology, Oncology and Bone Marrow Transplantation with Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

Speaker: Panagiotis Malandrakis, MD (he/him/his) – Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece

Speaker: S. Vincent Rajkumar, MD – Mayo Clinic

Panelist: Sergio Giralt, MD – Memorial Sloan Kettering Cancer Center

Panelist: Thierry Facon, MD – University of Lille, CHU Lille, Service des Maladies du Sang, Lille, France

Panelist: Jean-Luc Harousseau, MD – INSTITUT DE CANCEROLOGIE DE L'OUEST FRANCE

Panelist: Vania Hungria, MD, PhD – Department of Hematology, Clinica São Germano, São Paulo, Brazil

Panelist: Michele Cavo (he/him/his) – IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seràgnoli”, Università degli Studi di Bologna, Bologna, Italy

Panelist: Bindu Kanapuru

Co-Chair: Morie A. Gertz, MD, MACP (he/him/his) – Mayo Clinic

Co-Chair: Hartmut Goldschmidt, MD – Department of Medicine V, University Hospital Heidelberg; and National Center for Tumor Diseases (NCT)

Speaker: Camila Guerrero – Clínica Universidad de Navarra, Centro de Investigación Médica Aplicada (CIMA), Instituto de Investigación Sanitaria de Navarra (IDISNA), CIBER-ONC number CB16/12/00369

Speaker: Annika Werly – Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany

Speaker: Charan T R Vegivinti, MD (he/him/his) – Jacobi Medical Center / Albert Einstein College of Medicine

Speaker: Jens Hillengass, MD, PhD – Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA

Speaker: Albert Oriol, PhD (he/him/his) – Catalan Institute of Oncology and Josep Carreras Institute, Hospital Germans Trias i Pujol, Badalona, Spain

Co-Chair: Annemiek Broijl, MD, PhD (she/her/hers) – ErasmusMC

Co-Chair: Lugui Qiu, MD (he/him/his) – Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences.

Speaker: Elizabeth D. Lightbody, PhD – Dana-Farber Cancer Institute

Speaker: Afsaneh Panahi, MSc – BC Cancer Research Centre/ University of British Columbia

Speaker: wei tan, Ph.D – The University of Texas MD Anderson Cancer Center

Speaker: Frits van Rhee, MD PHD (he/him/his) – Myeloma Center, University of Arkansas of Medicine

Speaker: Hao Mu, Principle Investigation (she/her/hers) – State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China.

Speaker: S. Vincent Rajkumar, MD – Mayo Clinic

Speaker: Siddhartha Mukherjee

Speaker: Sagar Lonial, MD, FACP – Emory University School of Medicine, Atlanta, GA, USA

Speaker: Marc S. Raab, MD (he/him/his) – Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany and Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany

Speaker: Charlotte Pawlyn, PhD, FRCP, FRCPath – The Institute of Cancer Research

Speaker: Enrique M. Ocio, MD, PhD – Hospital Universitario Marqués de Valdecilla (IDIVAL), Santander, Spain

Speaker: Adam S. Sperling, MD, PhD (he/him/his) – Brigham and Women's Hospital

Speaker: Ashutosh D. Wechalekar, MD – University College Hospital

Speaker: Vaishali Sanchorawala, MD (she/her/hers) – Boston University Chobanian & Avedisian School of Medicine

Speaker: Andrew J. Yee, MD – Massachusetts General Hospital Cancer Center

Speaker: Efstathios Kastritis, MD, PhD (he/him/his) – National and Kapodistrian University of Athens

Speaker: Pankaj Malhorta, MD – Postgraduate Institute of Medical Education and Research

Speaker: Elena Zamagni, Sr., MD, PhD (she/her/hers) – European Myeloma Network, Italy

Speaker: Jens Hillengass, MD, PhD – Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA

Speaker: Lalit Kumar, MD, DM (he/him/his) – Oncology and BMT, Artemis Hospitals, Gurugram122001, India

Speaker: Craig E. Cole, MD – Michigan State University-Karmanos Cancer Institute

Speaker: Nelson Leung, MD – Division of hematology and Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN

Co-Chair: Pieter Sonneveld, MD, PhD (he/him/his) – EMN

Co-Chair: Nikhil Munshi, MD – Dana-Farber Cancer Institute, Harvard Medical School

Speaker: Paolo Ghia, MD. PhD (he/him/his) – Università Vita-Salute San Raffaele

Speaker: Jacqueline Cloos, PhD (she/her/hers) – Amsterdam UMC, location VUMC, Cancer Center Amsterdam

Speaker: Nicole Gormley, MD – U.S. Food and Drug Administration

Chair: Kenneth C. Anderson, MD – The LeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA

Co-Chair: Gareth Morgan, MD, PHD, FRCP, FRCPATH (he/him/his) – NYU Langone Health Perlmutter Cancer Center

Speaker: Irene Ghobrial, MD (she/her/hers) – Dana-Farber Cancer Institute, Boston, MA, USA

Speaker: Mala Shanmugam, MS, PhD (she/her/hers) – Winship Cancer Institute, Emory University

Speaker: Felipe Prosper, MD (he/him/his) – Clinica Universidad de Navarra

Speaker: Arun P. Wiita, MD, PhD – University of California San Francisco, San Francisco, CA, USA

Speaker: Maximilian Merz, MD (he/him/his) – University of Leipzig

Speaker: Laura Lucia Cogrossi – San Raffaele Scientific Institute

Speaker: Andrea Poletti, PhD – IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seràgnoli” - Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Università di Bologna, Bologna, Italy

Speaker: Gareth Morgan, MD, PHD, FRCP, FRCPATH (he/him/his) – NYU Langone Health Perlmutter Cancer Center

Panelist: Sonja Zweegman, MD, PhD – Amsterdam UMC

Panelist: Herve Avet-Loiseau, MD, PhD (he/him/his) – IUC-Oncopole

Panelist: Wilson I. Gonsalves, MD – Mayo Clinic, Rochester

Panelist: Jill CORRE, PharmD, PhD (she/her/hers) – Institut Universitaire du Cancer de Toulouse-Oncopole

Chair: Michel Delforge, MD/Phd – University of Leuven, Leuven, Belgium

Chair: Michel Delforge, MD/Phd – University of Leuven, Leuven, Belgium

Speaker: Leo Rasche, MD – Department of Internal Medicine II, University Hospital, 97080 Würzburg, Germany

Speaker: Michel Delforge, MD/Phd – University of Leuven, Leuven, Belgium

Speaker: Roberto Mina, MD – European Myeloma Network, Italy

Chair: Philippe Moreau, MD – University Hospital Hôtel-Dieu, Nantes, France

Co-Chair: Sagar Lonial, MD, FACP – Emory University School of Medicine, Atlanta, GA, USA

Speaker: Nizar J. Bahlis, MD – Arnie Charbonneau Cancer Institute - University of Calgary

Speaker: Lawrence Boise, PhD (he/him/his) – Emory University

Speaker: Suzanne Lentzsch, MD, PhD (she/her/hers) – Columbia University

Speaker: Paula Rodriguez-Otero, MD PhD (she/her/hers) – Clinica Universidad de Navarra

Speaker: Shuntaro Ikegawa, MD, PhD – Dana-Farber Cancer Institute

Speaker: Alexandra M. Poos, PhD (she/her/hers) – Multiple Myeloma Section, Department of Medicine V, University Hospital Heidelberg

Speaker: Leo Rasche, MD – Department of Internal Medicine II, University Hospital, 97080 Würzburg, Germany

Speaker: Sagar Lonial, MD, FACP – Emory University School of Medicine, Atlanta, GA, USA

Panelist: P. Joy Ho, MBBS DPhil FRACP FRCPA (she/her/hers) – Institute of Haematology, Royal Prince Alfred Hospital

Panelist: Keith Stewart, MB ChB – Princess Margaret Cancer Centre, University Health Network

Panelist: MELETIOS DIMOPOULOS, MD (he/him/his) – Department of Clinical Therapeutics/Medical School/National and Kapodistrian University of Athens

Panelist: Donna E. Reece, MD – University Health Network, Princess Margaret Cancer Centre

Panelist: Ajai Chari, MD, PhD – Icahn School of Medicine at Mount Sinai, New York, NY, USA

Panelist: Bindu Kanapuru

Co-Chair: Gordon Cook, PhD – Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK

Co-Chair: Eirini Katodritou, MD, PhD (she/her/hers) – Department of Hematology, Theagenion Cancer Hospital, Thessaloniki, Greece

Speaker: Darrell White, MD (he/him/his) – Dalhousie University and Queen Elizabeth II Health Sciences Centre

Speaker: Jonathan L. Kaufman, MD – Winship Cancer Institute of Emory University

Speaker: Meral Beksac, MD (she/her/hers) – Ankara University

Speaker: Samer Al Hadidi, MD,MS,FACP – the University of Arkansas for Medical Sciences

Speaker: Cyrille Touzeau, MD, PhD – CHU Nantes

Co-Chair: Masood A. Shammas, PhD – Dana Farber Cancer Institute and VA Boston Healthcare System, Boston, MA, USA

Co-Chair: Mark Bustoros, MD – Meyer Cancer Center, Weill Cornell Medicine, Cornell University

Speaker: Kylee Maclachlan, MBChB, PhD – Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York City NY, USA

Speaker: Linda B. Baughn, PhD (she/her/hers) – Mayo Clinic, Rochester, MN, US

Speaker: Jiye Liu, PhD (he/him/his) – Dana-Farber Cancer Institute

Speaker: Takahiro Kamiya, MD (he/him/his) – Division of Stem Cell and Molecular Medicine, Center for Stem Cell Biology and Regenerative Medicine, Institute of Medical Science, The University of Tokyo, Tokyo, Japan / Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan

Speaker: Jian Cui – Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Science & Peking Union Medical College

Speaker: Paola Neri, MD PhD – Arnie Charbonneau Cancer Research Institute, University of Calgary

Speaker: Mehmet K. Samur, PhD – Dana-Farber Cancer Institute

Speaker: Ajay K. Nooka, MD, MPH (he/him/his) – Winship Cancer Institute, Emory University School of Medicine

Speaker: Suzanne Trudel, MD – Princess Margaret Cancer Centre, Toronto, ON, Canada

Speaker: Tanya Wildes, MD, MSCI (she/her/hers) – University of Nebraska Medical Center/Nebraska Medicine

Speaker: Raphael Szalat, MD; PhD (he/him/his) – Boston University Chobanian & Avedisian School of Medicine

Speaker: David Avigan, MD (he/him/his) – Beth Israel Deaconess Medical Center

Speaker: Heinz Ludwig, MD – Department of Medicine I, Wilhelminen Cancer Research Institute, Klinik Ottakring

Speaker: Mariateresa Fulciniti, PhD – Dana Farber Cancer Institute

Speaker: Niccolo Bolli, Prof. – University of Milan

Speaker: Constantine S. Mitsiades, MD, PhD – Dana Farber Cancer Institute

Speaker: Manoj Bhasin, PhD – Emory University

Speaker: Samir Parekh, MD – Mount Sinai Medical Center, New York, NY, USA

Speaker: Brian A. Walker, PhD (he/him/his) – Indiana University

Speaker: Prashant Kapoor, MD – Mayo Clinic

Speaker: Veronique Leblond, MD (she/her/hers) – Sorbonne Université

Co-Chair: Nikhil Munshi, MD – Dana-Farber Cancer Institute, Harvard Medical School

Co-Chair: Kenneth C. Anderson, MD – The LeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA

Speaker: Jens Lohr, MD, PhD – Dana-Farber Cancer Institute

Speaker: Raphael Szalat, MD; PhD (he/him/his) – Boston University Chobanian & Avedisian School of Medicine

Speaker: Flavia Pichiorri, PhD (she/her/hers) – City of Hope

Speaker: Marc-A. Baertsch, MD – German Cancer Research Center (DKFZ)

Chair: Jesus San Miguel, PhD. MD. (he/him/his) – Clínica Universidad de Navarra

Co-Chair: Noopur Raje, MD – Massachusetts General Hospital Cancer Center

Speaker: Adam D Cohen, MD – Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA

Speaker: Niels van de Donk, MD PhD (he/him/his) – Amsterdam UMC

Speaker: Krina K. Patel, MD (she/her/hers) – MD Anderson Cancer Center, University of Texas, Houston, TX, USA

Speaker: Joshua Richter, MD – Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA

Speaker: Hui Liu, LH – Department of Hematology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Science, China

Speaker: Luis-Esteban Tamariz-Amador, MD – Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), IdiSNA

Speaker: Niels van de Donk, MD PhD (he/him/his) – Amsterdam UMC

Speaker: Noopur Raje, MD – Massachusetts General Hospital Cancer Center

Panelist: Jesus G. Berdeja, MD – Sarah Cannon Research Institute

Panelist: Ivan Borrello, MD – Tampa General Hospital

Panelist: Tom Martin, MD (he/him/his) – UCSF

Panelist: Monika Engelhardt

Panelist: Sham Mailankody, MBBS – Memorial Sloan Kettering Cancer Center

Chair: Paul G. Richardson, MD – Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA

Speaker: Alessandra Larocca, MD, PhD – University of Torino

Speaker: Yael C. Cohen, MD – Tel- Aviv Sourasky (Ichilov) Medical Center, and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel

Speaker: Paul G. Richardson, MD – Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA

Speaker: Hang Quach, MBBS(Hons) SpecCertOC FRACP FRCPA MD – St Vincent’s Hospital Melbourne, University of Melbourne, VIC, Australia

Co-Chair: Robert Z. Orlowski, PhD, MD (he/him/his) – The University of Texas MD Anderson Cancer Center

Co-Chair: Qing Yi, MD, PhD (he/him/his) – Houston Methodist Neal Cancer Center

Speaker: Alejandro Medina-Herrera, PhD – Departamento de Hematología, Hospital Universitario de Salamanca, (HUSA/IBSAL), Centro de Investigación del Cáncer-IBMCC (CSIC/USAL), CIBERONC

Speaker: Samir Parekh, MD – Mount Sinai Medical Center, New York, NY, USA

Speaker: Parvathi Sudha, MS (she/her/hers) – Melvin and Bren Simon Comprehensive Cancer Center, Division of Hematology and Oncology, School of Medicine, Indiana University, Indianapolis, IN, USA

Speaker: Paola Neri, MD PhD – Arnie Charbonneau Cancer Research Institute, University of Calgary

Speaker: Carlos Fernandez de Larrea, MD, PhD – Hospital Clínic de Barcelona

Speaker: Tom Martin, MD (he/him/his) – UCSF

Speaker: Philippe Moreau, MD – University Hospital Hôtel-Dieu, Nantes, France

Speaker: Sagar Lonial, MD, FACP – Emory University School of Medicine, Atlanta, GA, USA

Speaker: Maria-Victoria Mateos, PhD (she/her/hers) – University Hospital of Salamanca

Speaker: Faith E. Davies, MD (she/her/hers) – Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA

Speaker: Noemi Puig, MD, PhD – Hospital Universitario de Salamanca, Instituto de investigación biomédica de Salamanca (IBSAL)

Speaker: Kenneth C. Anderson, MD – The LeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA

Co-Chair: Katja Weisel, MD (she/her/hers) – University Medical Center of Hamburg-Eppendorf, Hamburg, Germany

Co-Chair: Simon J. Harrison, MBBS, MRCP(uk), FRCPath(uk), FRACP, PhD (he/him/his) – Peter MacCallum Cancer Centre

Speaker: Simon J. Harrison, MBBS, MRCP(uk), FRCPath(uk), FRACP, PhD (he/him/his) – Peter MacCallum Cancer Centre

Speaker: Shonali Midha, MD – Dana Farber Cancer Institute

Speaker: Salomon Manier, MD, PhD – Centre Hospitalier Universitaire de Lille, Université de Lille, Lille, France

Speaker: Jieyun Xia, MD – The Affiliated Hospital of Xuzhou Medical University

Speaker: Eyal Lebel, MD – Hadassah medical center

Co-Chair: Eileen M. Boyle, MD PhD – UCL Cancer Institute

Co-Chair: Fanghuang Zhan, MD & PhD (he/him/his) – University of Arkasas Medical Sciences

Speaker: Brian A. Walker, PhD (he/him/his) – Indiana University

Speaker: Jessica Encinas Mayoral (she/her/hers) – Fundación Investigación Biomédica Hospital 12 de Octubre

Speaker: Aintzane Zabaleta, PhD (she/her/hers) – CIMA (Pamplona)

Speaker: Jian Cui – Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Science & Peking Union Medical College

Speaker: Ross S. Firestone, MD/PhD (he/him/his) – Memorial Sloan Kettering Cancer Center, New York City NY, USA

Speaker: Jens Lohr, MD, PhD – Dana-Farber Cancer Institute

Speaker: Mattia D'Agostino, MD – University of Turin

Speaker: Marta Sonia González, MD (she/her/hers) – H CLINICO UNIVERSITARIO SANTIAGO DE COMPOSTELA

Speaker: Claudio Cerchione, n/a (he/him/his) – Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy

Speaker: Angela Dispenzieri, MD – Mayo Clinic Rochester

Speaker: Frits van Rhee, MD PHD (he/him/his) – Myeloma Center, University of Arkansas of Medicine

Speaker: Dave Murray, MD PhD – Mayo Clinic

Speaker: Joan Bladé, MD PhD – Amyloidosis and Myeloma Unit. Hospital Clínic de Barcelona. IDIBAPS. University of Barcelona. Barcelona, Spain

Speaker: Jorge J. Castillo, MD (he/him/his) – Dana-Farber Cancer Institute

Speaker: Andrew R. Branagan, MD, PhD – Massachusetts General Hospital

Speaker: Meral Beksac, MD (she/her/hers) – Ankara University

Speaker: Natalie Callander, MD – University of Wisconsin

Speaker: Carlos Fernandez de Larrea, MD, PhD – Hospital Clínic de Barcelona

Speaker: Andrzej J. Jakubowiak, MD, PhD – University of Chicago, Chicago, IL, USA

Speaker: Karthik Ramasamy, MBBS FRCP FRCPath PhD – University of Oxford and Oxford University Hospitals NHS FT

Speaker: Dorotea Fantl, MD – Hospital Italiano de Buenos Aires, Argentina.

Co-Chair: MELETIOS DIMOPOULOS, MD (he/him/his) – Department of Clinical Therapeutics/Medical School/National and Kapodistrian University of Athens

Co-Chair: Efstathios Kastritis, MD, PhD (he/him/his) – National and Kapodistrian University of Athens

Speaker: Steven Treon, MD, PhD, FACP, FRCP (he/him/his) – Dana Farber Cancer Institute

Speaker: Vaishali Sanchorawala, MD (she/her/hers) – Boston University Chobanian & Avedisian School of Medicine

Chair: Joseph Mikhael, MD – Translational Genomics Research Institute (TGen), City of Hope Cancer Center

Speaker: Joseph Mikhael, MD – Translational Genomics Research Institute (TGen), City of Hope Cancer Center

Speaker: Xavier P. Leleu, MD, PhD (he/him/his) – Hospital La Mileterie, Poitiers, France

Speaker: Fredrik Schjesvold, MD, PhD – Oslo Myeloma Center, Department of Hematology, Oslo University Hospital and KG Jebsen Center for B Cell Malignancies, University of Oslo

Speaker: Elizabeth O'Donnell, MD – Massachusetts General Hospital

Chair: Shaji K. Kumar, MD – Mayo Clinic, Rochester, MN, US

Co-Chair: Francesca Gay, MD – Division of Hematology 1, Clinical trial unit AOU città della salute e della scienza, University of Torino

Speaker: Martin F. Kaiser, MD, FRCP, FRCPath – The Institute of Cancer Research; Royal Marsden Hospital

Speaker: Moritz Binder, MD MPH (he/him/his) – Mayo Clinic

Speaker: Laura Rosinol, MD, PhD (she/her/hers) – Hospital Clínic de Barcelona, IDIBAPS, Barcelona, Spain

Speaker: Salomon Manier, MD, PhD – Centre Hospitalier Universitaire de Lille, Université de Lille, Lille, France

Speaker: Ioannis V Kostopoulos, n/a – Section of Animal and Human Physiology, Department of Biology, School of Sciences, National and Kapodistrian University of Athens, Athens, Greece

Speaker: Clark DuMontier, MD, MPH (he/him/his) – VA Boston Healthcare System and Brigham and Women's Hospital/Harvard Medical School

Speaker: Hira Mian, MD, MSc, FRCPC – McMaster University, Hamilton, Ontario, Canada

Speaker: Francesca Gay, MD – Division of Hematology 1, Clinical trial unit AOU città della salute e della scienza, University of Torino

Panelist: Wee Joo Chng, MB ChB, PhD, FRCP (UK), FRCPath (UK), FAMS – National University Cancer Institute, Singapore

Panelist: Sundar Jagannath, MD, FASCO – Mount Sinai Medical Center, New York, NY, USA

Panelist: Hira Mian, MD, MSc, FRCPC – McMaster University, Hamilton, Ontario, Canada

Panelist: Cristina Gasparetto, MD (she/her/hers) – Department of Medicine, Duke University Cancer Institute, Durham, NC

Panelist: Mohamad Mohty, MD, PhD – Sorbonne University, Saint-Antoine Hospital, AP-HP INSERM UMRs 938, Paris, France

Speaker: Suzanne Lentzsch, MD, PhD (she/her/hers) – Columbia University

Speaker: Andrew R. Branagan, MD, PhD – Massachusetts General Hospital

Speaker: Ravi Vij, MD MBA – Washington University in St. Louis